{ "ok": true, "cik": "1077183", "ticker": "NEO", "name": "NeoGenomics, Inc.", "filings": [ { "form": "8-K", "filed": "2026-10-05", "items": [ "2.02 Results of Operations and Financial Condition", "5.02 Departure or Election of Directors; Appointment of Officers", "5.03 Amendments to Articles or Bylaws; Change in Fiscal Year", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1077183/000107718326000069/0001077183-26-000069-index.htm" }, { "form": "8-K", "filed": "2026-08-11", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers" ], "url": "https://www.sec.gov/Archives/edgar/data/1077183/000162828026055697/0001628280-26-055697-index.htm" }, { "form": "10-Q", "filed": "2026-07-28", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1077183/000107718326000059/0001077183-26-000059-index.htm" }, { "form": "8-K", "filed": "2026-07-28", "items": [ "2.02 Results of Operations and Financial Condition", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1077183/000107718326000058/0001077183-26-000058-index.htm" }, { "form": "8-K", "filed": "2026-07-20", "items": [ "7.01 Regulation FD Disclosure", "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1077183/000107718326000045/0001077183-26-000045-index.htm" }, { "form": "8-K", "filed": "2026-06-25", "items": [ "5.02 Departure or Election of Directors; Appointment of Officers", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1077183/000162828026045350/0001628280-26-045350-index.htm" } ], "events12m": 14, "healthWatch": { "window": "last 12 months", "since": "2025-10-06", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 6, "latest": { "filed": "2026-10-05", "url": "https://www.sec.gov/Archives/edgar/data/1077183/000107718326000069/0001077183-26-000069-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001077183.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1077183" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up NeoGenomics, Inc. ($NEO). Last filing: 8-K (2.02 Results of Operations and Financial Condition), 2026-10-05. 14 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 727332000, "revenueGrowth1y": 0.10107392751065003, "revenueGrowthPerYear": 0.10700110749336389, "yearsOfData": 5, "operatingMargin": -0.15932339014370328, "operatingMarginPrior": -0.1394349694050254, "netMargin": -0.14852227043495955, "operatingCashFlow": 5230000, "capitalSpending": 27008000, "freeCashFlow": -21778000, "researchAndDevelopment": 37077000, "researchShareOfRevenue": 0.05097672039728762, "cash": 159618000, "longTermDebt": 341858000, "longTermDebtChange": -0.3682306066026996, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 484329000 }, { "fiscalYearEnd": "2022-12-31", "revenue": 509728000 }, { "fiscalYearEnd": "2023-12-31", "revenue": 591643000 }, { "fiscalYearEnd": "2024-12-31", "revenue": 660566000 }, { "fiscalYearEnd": "2025-12-31", "revenue": 727332000 } ], "totalEquity": 836562000, "totalAssets": 1359830000, "equityRatio": 0.6151960171492025, "returnOnEquity": -0.1291296998907433, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": null, "sharesOutstanding": 128101000, "bookValuePerShare": 6.530487662079141, "revenuePerShare": 5.677801110061592, "range80": { "low": 698491638.6855258, "high": 901239616.427344, "baseline": 809841624.3807842, "n": 4309, "band": "b01", "bandLabel": "$100M–1B", "method": "v4.1", "credibility": 0.5, "growthYears": 4, "ownVolatility": 0.04041564513394323, "classVolatility": 0.1022985825903761, "volatility": 0.07777668150413988 }, "ifPaceHeld": { "low": 698491638.6855258, "high": 901239616.427344 } }, "edgarette": "🔖 Exposure: revenue $727.3M (FY2025), total debt $341.9M. Experience: revenue up 10.1% on the year, up 10.7% a year over 4 years; operating margin -15.9%, down from -13.9%. Soundness: equity 61.5% of assets, return on equity -12.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $698.5M and $901.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $654.9M to $963.8M. A statistical range, not company guidance. Against peers (8 filers, $50M+ revenue, its industry group): operating margin -15.9% against a 14.9% median; growth 10.1% against 5.2%.", "peers": { "sic": 8734, "sicDescription": "Services-Testing Laboratories", "calendarYear": 2025, "minRevenue": 50000000, "depth": 3, "group": "873", "growth": [ 0.0521, 8 ], "opMargin": [ 0.1491, 8 ], "equityRatio": [ 0.3322, 8 ], "returnOnEquity": [ 0.2291, 8 ] }, "summary": "NeoGenomics (NEO) grew revenue 10.1% in FY2025 to $727 million, operating margin -15.9% against a 14.9% median for services-testing laboratories, equity 61.5% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
NeoGenomics, Inc. against its own record and its peers
Operating marginPeer median 14.9%-15.9%Revenue, on the yearPeer median 5.2%10.1%Equity of assetsPeer median 33.2%61.5%Return on equityPeer median 22.9%-12.9%Gold tick: the median of 8–8 peers with $50M+ revenue in services-testing laboratories
", "chartHorizon": null, "backtest": { "tests": 6, "hits": 6, "rate": 1, "method": "v4", "byYear": { "2020": [ 1, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-10-06T14:06:26.605Z", "hash": "2c628cf34ad4d9f3", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "NeoGenomics (NEO) grew revenue 10.1% in FY2025 to $727 million, operating margin -15.9% against a 14.9% median for services-testing laboratories, equity 61.5% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 727332000, "totalDebt": 341858000, "cash": 159618000 }, "experience": { "revenueGrowth1y": 0.10107392751065003, "revenueGrowthPerYear": 0.10700110749336389, "operatingMargin": -0.15932339014370328, "operatingMarginPrior": -0.1394349694050254, "netMargin": -0.14852227043495955, "freeCashFlow": -21778000 }, "soundness": { "equityRatio": 0.6151960171492025, "returnOnEquity": -0.1291296998907433, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 8734, "sicDescription": "Services-Testing Laboratories", "calendarYear": 2025, "minRevenue": 50000000, "depth": 3, "group": "873", "growth": [ 0.0521, 8 ], "opMargin": [ 0.1491, 8 ], "equityRatio": [ 0.3322, 8 ], "returnOnEquity": [ 0.2291, 8 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-10-06", "signals": [ { "code": "5.02", "label": "Director or officer change", "count": 6, "latest": { "filed": "2026-10-05", "url": "https://www.sec.gov/Archives/edgar/data/1077183/000107718326000069/0001077183-26-000069-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 698491638.6855258, "high": 901239616.427344, "baseline": 809841624.3807842, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 4309, "sizeBand": "$100M–1B", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341, "coverageAllYears": 0.6904374799277399, "stressCoverageAllYears": 0.819004992974709, "outcomeYears": [ 2019, 2025 ] }, "credibility": { "weightOnOwnRecord": 0.5, "growthYears": 4, "ownVolatility": 0.04041564513394323, "classVolatility": 0.1022985825903761, "pricedVolatility": 0.07777668150413988, "k": 3 }, "stress": { "low": 654879136.8836079, "high": 963751117.3038305, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 6, "hits": 6, "rate": 1, "method": "v4", "byYear": { "2020": [ 1, 1 ], "2021": [ 1, 1 ], "2022": [ 1, 1 ], "2023": [ 1, 1 ], "2024": [ 1, 1 ], "2025": [ 1, 1 ] }, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-10-06T14:06:26.605Z", "hash": "2c628cf34ad4d9f3", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001077183.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1077183" }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0072, "growth3y": 0.1258, "volatility": 0.0404, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.6152, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns 0.7% of revenue into operating cash; revenue growing 12.6% a year over three years; no common dividend.", "outside": "Among $100M-1B companies: 27th percentile for cash, 65th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$100M-1B", "cashPctInClass": 27, "growthPctInClass": 65, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 0, "name": "New ship", "plain": "no warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 5230000, "investing": -12336000, "financing": -200288000, "capitalSpending": 27008000, "free": -21778000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": -26723000, "free": -90865000 }, { "fiscalYearEnd": "2022-12-31", "operating": -65993000, "free": -96884000 }, { "fiscalYearEnd": "2023-12-31", "operating": -1953000, "free": -30705000 }, { "fiscalYearEnd": "2024-12-31", "operating": 7023000, "free": -34038000 }, { "fiscalYearEnd": "2025-12-31", "operating": 5230000, "free": -21778000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 159618000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 1359830000, "ladder": null, "currentRatio": 4.26, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": { "fiscalYear": 2025, "cashConversion": 0.0072, "growth3y": 0.1258, "volatility": 0.0404, "paysDividend": false, "raisedDividend": false, "equityRatio": 0.6152, "quadrant": { "code": "fs", "label": "Fast and steady", "plain": "growing faster than its size class, with steadier revenue" }, "compass": { "code": "notyet", "inside": "Turns 0.7% of revenue into operating cash; revenue growing 12.6% a year over three years; no common dividend.", "outside": "Among $100M-1B companies: 27th percentile for cash, 65th for growth.", "emoji": "⚡", "label": "Fast, cash not yet", "plain": "growing fast, but little cash arriving so far" }, "band": "$100M-1B", "cashPctInClass": 27, "growthPctInClass": 65, "source": "SEC XBRL frames, the company’s own audited figures; quadrant split at the median of its size class" }, "harbor": { "signs": [], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 0, "name": "New ship", "plain": "no warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": 5230000, "investing": -12336000, "financing": -200288000, "capitalSpending": 27008000, "free": -21778000, "trend": [ { "fiscalYearEnd": "2021-12-31", "operating": -26723000, "free": -90865000 }, { "fiscalYearEnd": "2022-12-31", "operating": -65993000, "free": -96884000 }, { "fiscalYearEnd": "2023-12-31", "operating": -1953000, "free": -30705000 }, { "fiscalYearEnd": "2024-12-31", "operating": 7023000, "free": -34038000 }, { "fiscalYearEnd": "2025-12-31", "operating": 5230000, "free": -21778000 } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 159618000, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 1359830000, "ladder": null, "currentRatio": 4.26, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }